logo

BioVaram, Teijin in pact for collaboration

Teijin will support development and commercialisation in Japan of BioVaram’s pipeline, including exosome-based diagnostics and therapeutics, extracellular matrix (ECM) mimics, and bio-derived materials such as Type I atelocollagen

Read Full

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *